Sign in

CIK 0001661998

  • Non-accelerated filer
  • Smaller reporting company

Q32 Bio Inc.

Sign in to watch
Ticker
QTTB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473468154
Phone
+1 781-999-0232
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Former names
Q32 Bio Inc., Homology Medicines, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy Director bought 1,875,000 shares at $8.00 ($15,000,000)
  9. 4 Open-market buy Director bought 1,875,000 shares at $8.00 ($15,000,000)
  10. 4 Grant or award Chief Scientific Officer acquired 37,500 shares (grant or award)
  11. 4 Grant or award CEO acquired 132,000 shares (grant or award)
  12. 4 Grant or award CFO and President acquired 53,250 shares (grant or award)
  13. 4 Open-market sale CFO and President sold 3,995 shares at $4.51 ($18,035)
  14. 4 Open-market sale CEO sold 9,896 shares at $4.51 ($44,675)
  15. 4 Open-market sale Chief Scientific Officer sold 2,815 shares at $4.51 ($12,708)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale CEO sold 22,506 shares at $3.46 ($77,871)
  20. 4 Open-market sale CFO and President sold 9,072 shares at $3.46 ($31,395)

Page 2 of 15 · 295 filings